Dismantling cognitive–behavioral treatment for panic disorder: Questioning the utility of breathing retraining.

2000 ◽  
Vol 68 (3) ◽  
pp. 417-424 ◽  
Author(s):  
Norman B. Schmidt ◽  
Kelly Woolaway-Bickel ◽  
Jack Trakowski ◽  
Helen Santiago ◽  
Julie Storey ◽  
...  
1993 ◽  
Vol 31 (3) ◽  
pp. 279-287 ◽  
Author(s):  
Michael J. Telch ◽  
John A. Lucas ◽  
Norman B. Schmidt ◽  
Henry H. Hanna ◽  
T.LaNae Jaimez ◽  
...  

Author(s):  
David H. Barlow ◽  
Laren R. Conklin ◽  
Kate H. Bentley

A substantial number of strong studies have established the efficacy of cognitive-behavioral treatment for persons with panic disorder with or without agoraphobia. These treatments include some combination of cognitive elements, exposure to interoceptive sensations similar to physiological panic sensations, in vivo exposure, and breathing retraining. A number of excellent studies have established the clinical efficacy of situational in vivo exposure for patients with moderate to severe agoraphobia and specific phobia. The most common treatment approaches for social anxiety disorder include social skills training, relaxation techniques, exposure-based treatment methods, and multicomponent cognitive-behavioral treatments.


2013 ◽  
Vol 37 (5) ◽  
pp. 680-704 ◽  
Author(s):  
Lyne Marchand ◽  
André Marchand ◽  
Pierre Landry ◽  
Andrée Letarte ◽  
Joane Labrecque

2000 ◽  
Vol 14 (4) ◽  
pp. 381-392 ◽  
Author(s):  
Stefan G. Hofmann ◽  
Lynn F. Bufka ◽  
Stephen M. Brady ◽  
Curtiss Du Rand ◽  
Donald C. Goff

Many patients with schizophrenia suffer from panic disorder. Although Panic Control Treatment (PCT), a cognitive-behavioral intervention for panic disorder, has been found efficacious in a number of controlled studies with careful selection criteria for participants, little is known about the utility of this treatment for patients with schizophrenia who also suffer from panic disorder. Four patients with schizophrenia received 15-17 individual sessions of PCT for their panic disorder. After treatment, clinicians rated all patients’ panic disorder as less severe than at pretreatment, and three of the patients no longer met diagnostic criteria for panic disorder. Positive psychotic symptoms seem to improve as a result of treatment in some patients. Furthermore, a 6-month follow-up assessment of one patient suggests good maintenance of treatment gains. Although a modification of the treatment protocol seems necessary, the results point to the clinical utility of PCT for treating panic disorder in patients with schizophrenia. These findings suggest that a controlled clinical trial may be warranted.


Sign in / Sign up

Export Citation Format

Share Document